Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Share price will not move up

<< Previous

Bullboard Posts

Next >>

Comment by Joemareon Nov 09, 2022 11:31am

58 Views

Post# 35085456

RE:RE:Share price will not move up

They have 5 weeks to spill out the beans. Nothing of interest should be communicated between December 16th and January 3rd.

Actually, the more I think of it, they have 3 weeks. Corporate/executive scorecard 2022 comes to an end on Nov 30th.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023